CSNpharm

CSNpharm logo

Csnpharm is committed to providing you with high quality products and outstanding services. We supply over 5000 bioactive compounds in stock, including inhibitors, agonists and natural products for laboratory and scientific use. Csnpharm has always been committed to develop quality products that are validated by NMR, UPLC, LC-MS, GC, Chiral HPLC and so on. We have a professional technical support team for customer service with years of experience in life science. Csnpharm is your reliable partner for scientific research.

Company Website

Product Listing

Ixabepilone 1mg  | ≥98%

CSNpharm

Ixabepilone is a microtubule inhibitor working by binding to tubulin and promoting tubulin polymerization and microtubule stabilization.

More Information Supplier Page

Ixabepilone 10mg  | ≥98%

CSNpharm

Ixabepilone is a microtubule inhibitor working by binding to tubulin and promoting tubulin polymerization and microtubule stabilization.

More Information Supplier Page

Ixabepilone 50mg  | ≥98%

CSNpharm

Ixabepilone is a microtubule inhibitor working by binding to tubulin and promoting tubulin polymerization and microtubule stabilization.

More Information Supplier Page

Jaceosidin 10mg  | ≥99%

CSNpharm

Jaceosidin, a methylated trihydroxyflavone, can induce apoptosis in cancer cells via activating Bax and also could block signaling pathways related to inflammation. It is first isolated from the Compositae family.

More Information Supplier Page

Jaceosidin 50mg  | ≥99%

CSNpharm

Jaceosidin, a methylated trihydroxyflavone, can induce apoptosis in cancer cells via activating Bax and also could block signaling pathways related to inflammation. It is first isolated from the Compositae family.

More Information Supplier Page

Jaceosidin 250mg  | ≥99%

CSNpharm

Jaceosidin, a methylated trihydroxyflavone, can induce apoptosis in cancer cells via activating Bax and also could block signaling pathways related to inflammation. It is first isolated from the Compositae family.

More Information Supplier Page

Jaceosidin 25mg  | ≥99%

CSNpharm

Jaceosidin, a methylated trihydroxyflavone, can induce apoptosis in cancer cells via activating Bax and also could block signaling pathways related to inflammation. It is first isolated from the Compositae family.

More Information Supplier Page

Jaceosidin 100mg  | ≥99%

CSNpharm

Jaceosidin, a methylated trihydroxyflavone, can induce apoptosis in cancer cells via activating Bax and also could block signaling pathways related to inflammation. It is first isolated from the Compositae family.

More Information Supplier Page

Jaceosidin 5mg  | ≥99%

CSNpharm

Jaceosidin, a methylated trihydroxyflavone, can induce apoptosis in cancer cells via activating Bax and also could block signaling pathways related to inflammation. It is first isolated from the Compositae family.

More Information Supplier Page

JANEX-1 50mg  | ≥98%

CSNpharm

JANEX-1 is a cell-permeable, reversible, potent, ATP-competitive, and specific inhibitor of JAK3 (IC50 = 78 μM) and has no effect on JAK1, JAK2, or Zap/Syk or SRC tyrosine kinases.

More Information Supplier Page

JANEX-1 25mg  | ≥98%

CSNpharm

JANEX-1 is a cell-permeable, reversible, potent, ATP-competitive, and specific inhibitor of JAK3 (IC50 = 78 μM) and has no effect on JAK1, JAK2, or Zap/Syk or SRC tyrosine kinases.

More Information Supplier Page

JANEX-1 5mg  | ≥98%

CSNpharm

JANEX-1 is a cell-permeable, reversible, potent, ATP-competitive, and specific inhibitor of JAK3 (IC50 = 78 μM) and has no effect on JAK1, JAK2, or Zap/Syk or SRC tyrosine kinases.

More Information Supplier Page

JANEX-1 10mg  | ≥98%

CSNpharm

JANEX-1 is a cell-permeable, reversible, potent, ATP-competitive, and specific inhibitor of JAK3 (IC50 = 78 μM) and has no effect on JAK1, JAK2, or Zap/Syk or SRC tyrosine kinases.

More Information Supplier Page

Jasmone 100mg  | ≥95%

CSNpharm

Jasmone is a natural organic compound extracted from the volatile portion of the oil from jasmine flowers.

More Information Supplier Page

Jatrorrhizine 2mg  | ≥99%

CSNpharm

Jatrorrhizine is a protoberberine alkaloid isolated from some plant species like Enantia chlorantha. It can inhibit MAO-A and MAO-B noncompetitively with IC50 value of 4μM and 62μM, respectively. Also, it has antiinflammatory, antimicrobial and antifungal activity.

More Information Supplier Page

Jatrorrhizine 5mg  | ≥99%

CSNpharm

Jatrorrhizine is a protoberberine alkaloid isolated from some plant species like Enantia chlorantha. It can inhibit MAO-A and MAO-B noncompetitively with IC50 value of 4μM and 62μM, respectively. Also, it has antiinflammatory, antimicrobial and antifungal activity.

More Information Supplier Page

Jatrorrhizine 10mg  | ≥99%

CSNpharm

Jatrorrhizine is a protoberberine alkaloid isolated from some plant species like Enantia chlorantha. It can inhibit MAO-A and MAO-B noncompetitively with IC50 value of 4μM and 62μM, respectively. Also, it has antiinflammatory, antimicrobial and antifungal activity.

More Information Supplier Page

Jatrorrhizine 25mg  | ≥99%

CSNpharm

Jatrorrhizine is a protoberberine alkaloid isolated from some plant species like Enantia chlorantha. It can inhibit MAO-A and MAO-B noncompetitively with IC50 value of 4μM and 62μM, respectively. Also, it has antiinflammatory, antimicrobial and antifungal activity.

More Information Supplier Page

JG98 5mg  | ≥97%

CSNpharm

JG-98, an allosteric heat shock protein 70 (Hsp70) inhibitor which shows anti-cancer activities affecting both cancer cells and tumor-associated macrophages.

More Information Supplier Page

JG98 25mg  | ≥97%

CSNpharm

JG-98, an allosteric heat shock protein 70 (Hsp70) inhibitor which shows anti-cancer activities affecting both cancer cells and tumor-associated macrophages.

More Information Supplier Page

JG98 10mg  | ≥97%

CSNpharm

JG-98, an allosteric heat shock protein 70 (Hsp70) inhibitor which shows anti-cancer activities affecting both cancer cells and tumor-associated macrophages.

More Information Supplier Page

JG98 50mg  | ≥97%

CSNpharm

JG-98, an allosteric heat shock protein 70 (Hsp70) inhibitor which shows anti-cancer activities affecting both cancer cells and tumor-associated macrophages.

More Information Supplier Page

JG98 1mg  | ≥97%

CSNpharm

JG-98, an allosteric heat shock protein 70 (Hsp70) inhibitor which shows anti-cancer activities affecting both cancer cells and tumor-associated macrophages.

More Information Supplier Page

JND3229 10mg  | ≥99%

CSNpharm

JND3229 is a new highly potent EGFR(C797S) inhibitor with IC50 values of 5.8nM, 30.5nM and 6.8nM for EGFR (L858R/T790M/C797S), EGFR (T790M, L858R) and EGFR, respectively.

More Information Supplier Page

JND3229 5mg  | ≥99%

CSNpharm

JND3229 is a new highly potent EGFR(C797S) inhibitor with IC50 values of 5.8nM, 30.5nM and 6.8nM for EGFR (L858R/T790M/C797S), EGFR (T790M, L858R) and EGFR, respectively.

More Information Supplier Page

JNJ 47965567 100mg  | ≥99%

CSNpharm

JNJ 47965567 is a potent and selective P2X7 antagonist (pIC50 values are 8.3, 7.5 and 7.2 for human, mouse and rat receptors respectively).

More Information Supplier Page

JNJ 47965567 250mg  | ≥99%

CSNpharm

JNJ 47965567 is a potent and selective P2X7 antagonist (pIC50 values are 8.3, 7.5 and 7.2 for human, mouse and rat receptors respectively).

More Information Supplier Page

JNJ-5207852 5mg  | ≥99%

CSNpharm

JNJ-5207852 is a novel, non-imidazole histamine H3 receptor antagonist, with high affinity at the rat (pKi=8.9) and human (pKi=9.24) H3 receptor.

More Information Supplier Page

JNJ-5207852 10mg  | ≥99%

CSNpharm

JNJ-5207852 is a novel, non-imidazole histamine H3 receptor antagonist, with high affinity at the rat (pKi=8.9) and human (pKi=9.24) H3 receptor.

More Information Supplier Page

JNJ-5207852 50mg  | ≥99%

CSNpharm

JNJ-5207852 is a novel, non-imidazole histamine H3 receptor antagonist, with high affinity at the rat (pKi=8.9) and human (pKi=9.24) H3 receptor.

More Information Supplier Page

JNJ-5207852 25mg  | ≥99%

CSNpharm

JNJ-5207852 is a novel, non-imidazole histamine H3 receptor antagonist, with high affinity at the rat (pKi=8.9) and human (pKi=9.24) H3 receptor.

More Information Supplier Page

JNJ-5207852 100mg  | ≥99%

CSNpharm

JNJ-5207852 is a novel, non-imidazole histamine H3 receptor antagonist, with high affinity at the rat (pKi=8.9) and human (pKi=9.24) H3 receptor.

More Information Supplier Page

JNK Inhibitor IX 10mg  | ≥98%

CSNpharm

JNK Inhibitor IX can selectively inhibit JNK2 and JNK3 through targeting the ATP binding site with pIC50 of 6.5 and 6.7, respectively.

More Information Supplier Page

JNK Inhibitor IX 50mg  | ≥98%

CSNpharm

JNK Inhibitor IX can selectively inhibit JNK2 and JNK3 through targeting the ATP binding site with pIC50 of 6.5 and 6.7, respectively.

More Information Supplier Page

JNK Inhibitor IX 5mg  | ≥98%

CSNpharm

JNK Inhibitor IX can selectively inhibit JNK2 and JNK3 through targeting the ATP binding site with pIC50 of 6.5 and 6.7, respectively.

More Information Supplier Page

Josamycin 100mg  | Purity Not Available

CSNpharm

Josamycin is a macrolide antibiotic exhibiting antimicrobial activity against a wide spectrum of pathogens, such as bacteria. The dissociation constant Kd from ribosome for Josamycin is 5.5 nM.

More Information Supplier Page

Josamycin 25mg  | Purity Not Available

CSNpharm

Josamycin is a macrolide antibiotic exhibiting antimicrobial activity against a wide spectrum of pathogens, such as bacteria. The dissociation constant Kd from ribosome for Josamycin is 5.5 nM.

More Information Supplier Page

JTC-801 5mg  | ≥98%

CSNpharm

JTC-801 is a selective opioid receptor-like1 (ORL1) receptor antagonist with IC50 of 94 nM, and weakly inhibits receptors δ, κ, and μ.

More Information Supplier Page